Relafen 750, pharmacologically known as naproxen, showcases a fascinating illustration within the cellular pharmacy domain . Its mode of function copyrights on inhibiting cyclooxygenase catalysts , specifically COX-1 and COX-2, thereby reducing the synthesis of prostaglandins, which are vital mediators of pain and heat. This precise inhibition deli